Marked strain and substrain differences in induction of status epilepticus and subsequent development of neurodegeneration, epilepsy, and behavioral alterations in rats. Strain and substrain differences in an epilepsy model in rats

Epilepsy Research

Volumn 96, Issue 3, 2011, Pages 207-224

  Langer, Melanie ^a,b   Brandt, Claudia ^a,b   Löscher, Wolfgang ^a,b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b CENTER FOR SYSTEMS NEUROSCIENCE   (Germany)

Author keywords

Amygdala; Behavior; Hippocampal damage; Seizures; Sprague Dawley; Wistar

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIOR CHANGE; BREEDING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; DISEASE PREDISPOSITION; ELECTROSTIMULATION; ENVIRONMENTAL FACTOR; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; FEMALE; HEREDITY; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SPRAGUE DAWLEY RAT; STRAIN DIFFERENCE; WISTAR RAT;

ALLELES; AMYGDALA; ANIMALS; ANIMALS, OUTBRED STRAINS; BEHAVIOR, ANIMAL; BREEDING; DISEASE MODELS, ANIMAL; ENVIRONMENT; EPILEPSY, TEMPORAL LOBE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; MAZE LEARNING; NERVE DEGENERATION; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SPECIES SPECIFICITY; STATUS EPILEPTICUS;

EID: 80053920088     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.06.005     Document Type: Article

References (66)

1. Alahmed S., Herbert J. Strain differences in proliferation of progenitor cells in the dentate gyrus of the adult rat and the response to fluoxetine are dependent on corticosterone. Neuroscience 2008, 157:677-682.
2. André V., Ferrandon A., Marescaux C., Nehlig A. Vigabatrin protects against hippocampal damage but is not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res. 2001, 47:99-117.
3. André V., Dube C., Francois J., Leroy C., Rigoulot M.A., Roch C., Namer I.J., Nehlig A. Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model. Epilepsia 2007, 48(Suppl. 5):41-47.
4. Baars C., Löscher W., Leeb T., Becker A., Potschka H. Polymorphic variants of the multidrug resistance gene Mdr1a and response to antiepileptic drug treatment in the kindling model of epilepsy. Eur. J. Pharmacol. 2006, 550:54-61.
5. Bankstahl J.P., Löscher W. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus. Epilepsy Res. 2008, 82:70-85.
6. Beery A.K., Zucker I. Sex bias in neuroscience and biomedical research. Neurosci. Biobehav. Rev. 2011, 35:565-572.
7. Bethmann K., Brandt C., Löscher W. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy. Epilepsia 2007, 48:816-826.
8. Bethmann K., Fritschy J.M., Brandt C., Löscher W. Antiepileptic drug resistant rats differ from drug responsive rats in GABAA-receptor subunit expression in a model of temporal lobe epilepsy. Neurobiol. Dis. 2008, 31:169-187.
9. Beyenburg S., Mitchell A.J., Schmidt D., Elger C.E., Reuber M. Anxiety in patients with epilepsy: systematic review and suggestions for clinical management. Epilepsy Behav. 2005, 7:161-171.
10. Brandt C., Glien M., Potschka H., Volk H., Löscher W. Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats. Epilepsy Res. 2003, 55:83-103.
11. Brandt C., Volk H.A., Löscher W. Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus. Epilepsia 2004, 45:1488-1497.
12. Brandt C., Gastens A.M., Sun M.Z., Hausknecht M., Löscher W. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats. Neuropharmacology 2006, 51:789-804.
13. Brandt C., Bethmann K., Gastens A.M., Löscher W. The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol. Dis. 2006, 24:202-211.
14. Brandt C., Glien M., Gastens A.M., Fedrowitz M., Bethmann K., Volk H.A., Potschka H., Löscher W. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats. Neuropharmacology 2007, 53:207-221.
15. Brandt C., Schoendienst M., Trentowska M., May T.W., Pohlmann-Eden B., Tuschen-Caffier B., Schrecke M., Fueratsch N., Witte-Boelt K., Ebner A. Prevalence of anxiety disorders in patients with refractory focal epilepsy--a prospective clinic based survey. Epilepsy Behav. 2010, 17:259-263.
16. Burn C.C., Deacon R.M., Mason G.J. Marked for life? Effects of early cage-cleaning frequency, delivery batch, and identification tail-marking on rat anxiety profiles. Dev. Psychobiol. 2008, 50:266-277.
17. Curia G., Longo D., Biagini G., Jones R.S., Avoli M. The pilocarpine model of temporal lobe epilepsy. J. Neurosci. Methods 2008, 172:143-157.
18. Ettinger A.B., Copeland L.A., Zeber J.E., Van Cott A.C., Pugh M.J. Are psychiatric disorders independent risk factors for new-onset epilepsy in older individuals?. Epilepsy Behav. 2010, 17:70-74.
19. Fedrowitz M., Kamino K., Löscher W. Significant differences in the effects of magnetic field exposure on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in two substrains of Sprague-Dawley rats. Cancer Res. 2004, 64:243-251.
20. Festing M.F. Genetic variation in outbred rats and mice and its implications for toxicological screening. J. Exp. Anim. Sci. 1993, 35:210-220.
21. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 1993, 58:199-202.
22. Finn D.A., Gee K.W. The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J. Pharmacol. Exp. Ther. 1994, 271:164-170.
23. Francois J., Koning E., Ferrandon A., Nehlig A. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res. 2006, 72:147-163.
24. Fujikawa D.G., Itabashi H.H., Wu A., Shinmei S.S. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia 2000, 41:981-991.
25. Gastens A.M., Brandt C., Bankstahl J.P., Löscher W. Predictors of pharmacoresistant epilepsy: pharmacoresistant rats differ from pharmacoresponsive rats in behavioral and cognitive abnormalities associated with experimentally induced epilepsy. Epilepsia 2008, 49:1759-1767.
26. Gorter J.A., van Vliet E.A., Aronica E., Lopes Da Silva F.H. Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur. J. Neurosci. 2001, 13:657-669.
27. Hesdorffer D.C., Hauser W.A., Annegers J.F., Cascino G. Major depression is a risk factor for seizures in older adults. Ann. Neurol. 2000, 47:246-249.
28. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 1996, 54:21-30.
29. Honndorf S., Lindemann C., Tollner K., Gernert M. Female Wistar rats obtained from different breeders vary in anxiety-like behavior and epileptogenesis. Epilepsy Res. 2011, 94:26-38.
30. Hort J., Brozek G., Komarek V., Langmeier M., Mares P. Interstrain differences in cognitive functions in rats in relation to status epilepticus. Behav. Brain Res. 2000, 112:77-83.
31. Jacobs M.P., Leblanc G.G., Brooks-Kayal A., Jensen F.E., Lowenstein D.H., Noebels J.L., Spencer D.D., Swann J.W. Curing epilepsy: progress and future directions. Epilepsy Behav. 2009, 14:438-445.
32. Kacew S., Festing M.F. Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances. J. Toxicol. Environ. Health 1996, 47:1-30.
33. Kanner A.M. Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 2009, 15:83-87.
34. Kücker S., Töllner K., Piechotta M., Gernert M. Kindling as a model of temporal lobe epilepsy induces bilateral changes in spontaneous striatal activity. Neurobiol. Dis. 2010, 37:661-672.
35. Löscher W., Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol. Rev. 2010, 62:668-700.
36. Löscher W., Cramer S., Ebert U. Differences in kindling development in seven outbred and inbred rat strains. Exp. Neurol. 1998, 154:551-559.
37. Mills C.D., Hains B.C., Johnson K.M., Hulsebosch C.E. Strain and model differences in behavioral outcomes after spinal cord injury in rat. J. Neurotrauma 2001, 18:743-756.
38. Moser V.C., McCormick J.P., Creason J.P., MacPhail R.C. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundam. Appl. Toxicol. 1988, 11:189-206.
39. Pare W.P., Kluczynski J. Differences in the stress response of Wistar-Kyoto (WKY) rats from different vendors. Physiol. Behav. 1997, 62:643-648.
40. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Elsevier, Amsterdam. sixth ed.
41. Pitkänen A., Mathiesen C., Ronn L.C., Moller A., Nissinen J. Effect of novel AMPA antagonist NS1209, on status epilepticus. An experimental study in rat. Epilepsy Res. 2007, 74:45-54.
42. Pitkänen A., Kharatishvili I., Karhunen H., Lukasiuk K., Immonen R., Nairismagi J., Grohn O., Nissinen J. Epileptogenesis in experimental models. Epilepsia 2007, 48(Suppl. 2):13-20.
43. Portelli J., Aourz N., De Bundel D., Meurs A., Smolders I., Michotte Y., Clinckers R. Intrastrain differences in seizure susceptibility, pharmacological response and basal neurochemistry of Wistar rats. Epilepsy Res. 2009, 87:234-246.
44. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 2003, 463:3-33.
45. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroenceph. Clin. Neurophysiol. 1972, 32:281-294.
46. Rattka M., Brandt C., Bankstahl M., Bröer S., Löscher W. Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats. Neuropharmacology 2011, 60:505-512.
47. Rex A., Kolbasenko A., Bert B., Fink H. Choosing the right wild type: behavioral and neurochemical differences between 2 populations of Sprague-Dawley rats from the same source but maintained at different sites. J. Am. Assoc. Lab. Anim. Sci. 2007, 46:13-20.
48. Rice, A.C .
49. Floyd, C.L .
50. Lyeth, B.G .
51. Hamm, R.J
52. DeLorenzo, R.J ., 1998. Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits. Epilepsia 39, 1148-1157.
53. Robertson A., Campbell C., Milner P.M., Laferriere A. Rat strain differences in the acquisition of hippocampal self-stimulation. Brain Res. Bull. 1986, 16:369-375.
54. Scharfman H.E., MacLusky N.J. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 2006, 47:1423-1440.
55. Severino G.S., Fossati I.A., Padoin M.J., Gomes C.M., Trevizan L., Sanvitto G.L., Franci C.R., Anselmo-Franci J.A., Lucion A.B. Effects of neonatal handling on the behavior and prolactin stress response in male and female rats at various ages and estrous cycle phases of females. Physiol. Behav. 2004, 81:489-498.
56. Siller-Matula J.M., Jilma B. Strain differences in toxic effects of long-lasting isoflurane anaesthesia between Wistar rats and Sprague Dawley rats. Food Chem. Toxicol. 2008, 46:3550-3552.
57. Sloviter R.S. Hippocampal pathology and pathophysiology in temporal lobe epilepsy. Neurologia 1996, 11(Suppl. 4):29-32.
58. Sloviter R.S. Hippocampal epileptogenesis in animal models of mesial temporal lobe epilepsy with hippocampal sclerosis: the importance of the "latent period" and other concepts. Epilepsia 2008, 49(Suppl. 9):85-92.
59. Stables J.P., Bertram E., Dudek F.E., Holmes G., Mathern G., Pitkänen A., White H.S. Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop. Epilepsia 2003, 44:1472-1478.
60. Volk H.A., Löscher W. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain 2005, 128:1358-1368.
61. Volk H.A., Arabadzisz D., Fritschy J.M., Brandt C., Bethman K., Löscher W. Antiepileptic drug resistant rats differ from drug responsive rats in hippocampal neurodegeneration and GABAA-receptor ligand-binding in a model of temporal lobe epilepsy. Neurobiol. Dis. 2006, 21:633-646.
62. Wahnschaffe U., Löscher W. Lack of changes in seizure susceptibility during the estrous cycle in kindled rats. Epilepsy Res. 1992, 13:199-204.
63. White W.J., Lee C.S. The development and maintenance of the Crl:CD(SD)IGS BR rat breeding system. Biological Reference Data on CD(SD)IGS Rats-1998 1998, 8-14. Best Printing Co. Ltd., Tokyo, Japan. CD(SD)IGS Study Group (Ed.).
64. Xu B., McIntyre D.C., Fahnestock M., Racine R.J. Strain differences affect the induction of status epilepticus and seizure-induced morphological changes. Eur. J. Neurosci. 2004, 20:403-418.
65. Yilmazer-Hanke D.M. Morphological correlates of emotional and cognitive behaviour: insights from studies on inbred and outbred rodent strains and their crosses. Behav. Pharmacol. 2008, 19:403-434.
66. Zucker I., Beery A.K. Males still dominate animal studies. Nature 2010, 465:690.